Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRsJournal of Medical Virology, 2020-10 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25987Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variantsNature communications, 2021-10, Vol.12 (1), p.6103-6103, Article 6103 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-26401-w ;PMID: 34671049Full text available |
|
3 |
Material Type: Article
|
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategiesNature (London), 2020-12, Vol.588 (7839), p.682-687 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Dec 24-Dec 31, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2852-1 ;PMID: 33045718Full text available |
|
4 |
Material Type: Article
|
Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusionNature (London), 2020-12, Vol.588 (7837), p.327-330 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Dec 10, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2772-0 ;PMID: 32942285Full text available |
|
5 |
Material Type: Article
|
Structural variations in human ACE2 may influence its binding with SARS‐CoV‐2 spike proteinJournal of Medical Virology, 2020-09 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25832Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Coinfection with influenza A virus enhances SARS-CoV-2 infectivityCell research, 2021-04, Vol.31 (4), p.395-403 [Peer Reviewed Journal]The Author(s), under exclusive licence to Center for Excellence in Molecular Cell Science, CAS 2021. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;The Author(s), under exclusive licence to Center for Excellence in Molecular Cell Science, CAS 2021, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 1001-0602 ;EISSN: 1748-7838 ;DOI: 10.1038/s41422-021-00473-1 ;PMID: 33603116Full text available |
|
7 |
Material Type: Article
|
Bi-paratopic and multivalent VH domains block ACE2 binding and neutralize SARS-CoV-2Nature chemical biology, 2021-01, Vol.17 (1), p.113-121 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;ISSN: 1552-4450 ;EISSN: 1552-4469 ;DOI: 10.1038/s41589-020-00679-1 ;PMID: 33082574Full text available |
|
8 |
Material Type: Article
|
Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptorNature genetics, 2020-12, Vol.52 (12), p.1283-1293 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 2020 ;ISSN: 1061-4036 ;EISSN: 1546-1718 ;DOI: 10.1038/s41588-020-00731-9 ;PMID: 33077916Full text available |
|
9 |
Material Type: Article
|
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2Proceedings of the National Academy of Sciences - PNAS, 2020-11, Vol.117 (45), p.28046-28055 [Peer Reviewed Journal]Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Nov 10, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2016093117 ;PMID: 33093202Full text available |
|
10 |
Material Type: Article
|
ACE2 binding is an ancestral and evolvable trait of sarbecovirusesNature (London), 2022-03, Vol.603 (7903), p.913-918 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Mar 31, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04464-z ;PMID: 35114688Full text available |
|
11 |
Material Type: Article
|
Molecular insights into receptor binding energetics and neutralization of SARS-CoV-2 variantsNature communications, 2021-11, Vol.12 (1), p.6977-6977, Article 6977 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27325-1 ;PMID: 34848718Full text available |
|
12 |
Material Type: Article
|
A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agentNature structural & molecular biology, 2021-02, Vol.28 (2), p.202-209 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1545-9993 ;EISSN: 1545-9985 ;DOI: 10.1038/s41594-020-00549-3 ;PMID: 33432247Full text available |
|
13 |
Material Type: Article
|
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2Nature communications, 2022-01, Vol.13 (1), p.405-405, Article 405 [Peer Reviewed Journal]2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-27893-2 ;PMID: 35058437Full text available |
|
14 |
Material Type: Article
|
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersNature (London), 2022-03, Vol.603 (7902), p.687-692 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Mar 24, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04441-6 ;PMID: 35062015Full text available |
|
15 |
Material Type: Article
|
Angiotensin Converting Enzyme 2: A Double-Edged SwordCirculation (New York, N.Y.), 2020-08, Vol.142 (5), p.426-428 [Peer Reviewed Journal]2020 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.120.047049 ;PMID: 32213097Full text available |
|
16 |
Material Type: Article
|
Lack of Evidence of Angiotensin-Converting Enzyme 2 Expression and Replicative Infection by SARS-CoV-2 in Human Endothelial CellsCirculation (New York, N.Y.), 2021-02, Vol.143 (8), p.865-868 [Peer Reviewed Journal]2021 American Heart Association, Inc. 2021 ;ISSN: 0009-7322 ;ISSN: 1524-4539 ;EISSN: 1524-4539 ;DOI: 10.1161/circulationaha.120.052824 ;PMID: 33405941Full text available |
|
17 |
Material Type: Article
|
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolutionNature microbiology, 2021-09, Vol.6 (9), p.1188-1198 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2021. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 2058-5276 ;EISSN: 2058-5276 ;DOI: 10.1038/s41564-021-00954-4 ;PMID: 34400835Full text available |
|
18 |
Material Type: Article
|
Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2Nature communications, 2021-06, Vol.12 (1), p.3802-13, Article 3802 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-24013-y ;PMID: 34155214Full text available |
|
19 |
Material Type: Article
|
Tackling COVID-19 with neutralizing monoclonal antibodiesCell, 2021-06, Vol.184 (12), p.3086-3108 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.05.005 ;PMID: 34087172Full text available |
|
20 |
Material Type: Article
|
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive SpikeScience, 2020-12, Vol.370 (6523) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abe3255Digital Resources/Online E-Resources |